You just read:

Forty Seven, Inc. to Present Preliminary Data from its Ongoing Phase 1 Clinical Trial of 5F9 in Acute Myeloid Leukemia at the 23rd Congress of the European Hematology Association (EHA)

News provided by

Forty Seven, Inc.

May 17, 2018, 09:01 ET